+794.9%
MRNA vs VLTO
+21.9%
+773.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VLTO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.6% | -4.1% | -4.3% |
| 7D | -12.1% | +1.0% | -13.1% | -13.2% |
| 30D | -1.3% | +17.5% | -18.8% | -23.2% |
| 3M | +250.9% | +21.4% | +229.5% | +163.7% |
| 6M | +343.0% | +38.1% | +304.9% | +219.6% |
| YTD | +657.4% | +19.0% | +638.4% | +465.5% |
| 1Y | +794.9% | +20.7% | +774.3% | +565.3% |
| All | +794.9% | +21.9% | +773.0% | +565.3% |
Cumulative growth
Daily Returns
Daily percentage return beside VLTO.
Daily Out/Under-Performance
Portfolio return minus VLTO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VLTO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VLTO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling